TITLE

Quality by Design for Analytical Methods

AUTHOR(S)
Nethercote, Phil; Ermer, Joachim
PUB. DATE
October 2012
SOURCE
Pharmaceutical Technology Europe;Oct2012, Vol. 24 Issue 10, p52
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Adoption of quality-by-design (QbD) concepts in pharmaceutical development and manufacture is becoming increasingly well-established. QbD concepts are aimed at improving the robustness of manufacturing processes based upon adopting a systematic and scientific approach to development and implementing a control strategy based on the enhanced process understanding this provides. Many pharmaceutical companies have also recognised that QbD concepts can be used to improve the reliability of analytical methods. The authors describe how traditional approaches to analytical method transfer and validation may also benefit from alignment with QbD concepts and propose a three-stage concept to ensure that methods are suitable for their intended purpose throughout the analytical lifecycle: method design, method qualification and continued method verification. This paper represents a refinement and enhancement of the concepts originally proposed in an article written by P. Nethercote, T. Bennett, P. Borman, G. Martin and P. McGregor (1).
ACCESSION #
82215203

 

Related Articles

  • Early Development GMPs for Stability An Industry Perspective (Part IV). Acken, Bruce; Alasandro, Mark; Colgan, Stephen; Curry, Paul; Diana, Frank; Li, Q. Chan; Li, Z. Jane; Mazzeo, Tony; Rignall, Andy; Tan, Z. Jessica; Timpano, Robert // Pharmaceutical Technology Europe;Oct2012, Vol. 24 Issue 10, p61 

    The authors, part of the International Consortium on innovation and Quality in Pharmaceutical Development (IQ Consortium), explore and define common industry approaches and practices when applying GMPs in early development. A working group of the consortium aims to develop a set of...

  • Improving Tablet Quality with Compression to Equal Force Technology. van Evelghem, Johan // Pharmaceutical Technology;May2008 Supplement, Vol. 32, ps26 

    The article provides information on the compression technique that accounts for malleable strength and produces tablets with consistent weight and disintegration time. It relates that comprehension technique ensures the effectiveness of tablets and can be readily used by the body. It contends...

  • Using a Systematic Approach to Select Critical Process Parameters. Little, Thomas A. // BioPharm International;Jul2012, p52 

    The article focuses on the importance of critical process parameters (CPPs) and their process controls in the drug development and process validation. It mentions that the identification of the critical quality attributes (CQAs) for drug-product and substance is one of the main steps in the...

  • Quality by Design for APIs. Van Arnum, Patricia // Pharmaceutical Technology Europe;Sep2013, Vol. 25 Issue 9, p26 

    The article discusses the adoption of the quality by design for small-molecule drug manufacturing and development for the manufacturing process understanding of the active pharmaceutical ingredients (API). It mentions that this approach focuses on the development and manufacturing of drug...

  • Separation Science in Drug Development, Part II: High-Throughput Characterization. Baiwei Lin; Pease, Joseph H.; Dong, Michael W. // LC-GC North America;Aug2015, Vol. 33 Issue 8, p534 

    The article discusses high-throughput characterization techniques of drug development for supporting small-molecule drug discovery programs in pharmaceutical companies. It offers step-by-step instructions for quality control, purification of compounds of interest (COI) and identity confirmation...

  • Application of Quality by Design to Viral Safety. Remington, Kathryn Martin; Zehmer, John // BioPharm International;Oct2014, Vol. 27 Issue 10, p40 

    The article discusses the quality-by-design (QbD) approach implemented by the biotechnology industry to ensure the quality of biopharmaceuticals. It mentions that with QbD approach, products are developed with a thorough understanding of how the raw materials and manufacturing processes affect...

  • Continued Process Verification for Biopharma Manufacturing. Fleming, Jeff; Payne, Robin // BioPharm International;Oct2014, Vol. 27 Issue 10, p48 

    The article discusses the complications of implementing continued process verification (CPV) for biopharmaceutical manufacturing and provide recommended approaches. It states that CPV provides the manufacturer an assurance that a validated process remains in a validated state during the...

  • Transforming QC in controlled release.  // Life Science Today;Aug2000, Vol. 1 Issue 4, p18 

    Focuses on the reliability of texture analysis for assessing and quantifying rheological properties of controlled-release pharmaceutical products in Great Britain. Specification of texture analyzer; Accounts on the stages of pharmaceutical production process; Introduction of mucoadhesion rig...

  • LEAN & Mean. Chatterjee, Bikash // Pharmaceutical Processing;Feb2009, Vol. 24 Issue 2, p18 

    The article explores the value of applying operational excellence models in the development of a product's lifecycle. It discusses the operational models in developing product which include the six sigma models, lean manufacturing, and the pharma development framework. Moreover, it claims that...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics